RxNews®

Butrans^® (buprenorphine) – First-time generic

May 31, 2017 – Teva launched its authorized generic versions of Purdue Pharma’s Butrans (buprenorphine) 5 mcg/hr, 10 mcg/hr, 15 mcg/hr, and 20 mcg/hr transdermal systems.

Download PDF

Return to publications